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a b s t r a c t
Aggregates of amyloid-β (Aβ ) peptide are known to be the key pathological agents in Alzheimer disease (AD). Aβ aggregates to form large, insoluble ﬁbrils that deposit as senile plaques in AD brains. The
process of aggregation is nucleation–dependent in which the formation of a nucleus is the rate–limiting
step, and controls the physiochemical fate of the aggregates formed. Therefore, understanding the properties of nucleus and pre-nucleation events will be signiﬁcant in reducing the existing knowledge–gap
in AD pathogenesis. In this report, we have determined the plausible range of critical nucleation number (n∗ ), the number of monomers associated within the nucleus for a homogenous aggregation model
with single unique nucleation event, by two independent methods: A reduced-order stability analysis
and ordinary differential equation based numerical analysis, supported by experimental biophysics. The
results establish that the most likely range of n∗ is between 7 and 14 and within, this range, n∗ = 12
closely supports the experimental data. These numbers are in agreement with those previously reported,
and importantly, the report establishes a new modeling framework using two independent approaches
towards a convergent solution in modeling complex aggregation reactions. Our model also suggests that
the formation of large protoﬁbrils is dependent on the nature of n∗ , further supporting the idea that
pre-nucleation events are signiﬁcant in controlling the fate of larger aggregates formed. This report has
re-opened an old problem with a new perspective and holds promise towards revealing the molecular
events in amyloid pathologies in the future.
© 2015 Elsevier Inc. All rights reserved.

1. Introduction
Aggregates formed by misfolded proteins called amyloids have
emerged as the primary neurotoxic agents in neurodegenerative
diseases. In Alzheimer disease (AD), amyloid-β (Aβ ) peptide aggregates that eventually deposit as insoluble plaques observed in the
brains of AD patients. Aggregates of Aβ are responsible for synaptic dysfunction and neuronal death that consequently leads to cognitive decline [1]. Among the various aggregate forms of Aβ , lowmolecular weight forms ranging between dimers and 100mers are
implicated as the primary toxic agents along the aggregation pathway [1–3]. Therefore, there is an increased interest in understanding the precise mechanism of aggregation leading to various toxic
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forms. Several aspects of Aβ aggregation are well understood over
two decades of research. For example, Aβ aggregation towards
large ﬁbrillar deposits is a nucleation-dependent phenomenon that
follows a sigmoidal growth pattern involving a lag phase prior to
ﬁbril growth (Fig. 1). The lag-phase is a rate-limiting step during
which an important process of nucleation occurs [4,5]. Analogous
to crystal growth, the formation of nucleus dictates the outcome of
the ﬁbrils in terms of their rate of formation, structure and morphology [4,6]. It is widely known that the pre-nucleation events involve both conformational change and self-assembly of monomers
to a certain critical mass, which may form the ‘gatekeeper’ for the
entire aggregation pathway. However, precise understanding of aggregation especially during the pre-nucleation phase that deﬁnes
parameters such as the number of monomers associated in the
nucleus (nucleation number, n∗ ) and physiochemical nature of nucleus are far from clear.
During the past two decades, kinetics and thermodynamics
of Aβ aggregation have been intensely studied, and a number
of approaches and mathematical models have been developed
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Fig. 1. Aβ aggregation pathway. Schematic diagram indicating the salient aspects of Aβ aggregation towards ﬁbril formation. Important rate constants that are considered
in the model are shown. (Inset) The sigmoidal aggregation growth curve indicating three important phases of the reaction.

(reviewed in [7–10]). The molecular complexities involved in
aggregation process especially during the pre-nucleation stage,
and those in detecting and monitoring the process experimentally, necessitate modeling approaches that go beyond brute-force
methodologies. Unlike the widely believed thought, emerging
evidence based on coarse-grained simulations indicate that the
pre-nucleation itself may involve multiple steps and intermediates
to reach the critical nucleus size [11,12]. Previously, n∗ value for
amyloid protein, huntingtin was calculated to be ∼ 0.98 (for
polyglutamine, Q28 peptide) homogenous association [13]. Upon
incorporating conformational heterogeneity among the monomers
assembled within the nucleus, the values of n∗ were observed
to take on negative values [14]. Lee and co-workers adopted an
ordinary differential equation (ODE)-based simulation to model
insulin aggregation and utilized the previously predicted n∗ value
of 6 [15]. More recently, Saric and co-workers determined that
plausible nucleation size may range between 6 and 14 depending
on the initial monomer concentration [11].
The main reason for the paucity in nucleation-related information that precludes experimental characterization and conventional modeling is the complexity of the Aβ aggregation mechanism that has led to a confounding understanding of the prenucleation events. Accurate biophysical analysis is diﬃcult due
to the dynamic nature of the process that precludes precise experimental characterization. In particular, the lack of suﬃciently
sensitive experimental probes that could detect the presence of
a range of oligomers including those that are less populated
has further hindered experimental validation of the simulated
models. Detection of intermediate oligomers poses great diﬃculty to detect, let alone to isolate and characterize. Not surprisingly, only a few stable large (> 1500mers) intermediates
along the pathway such as protoﬁbrils (PFs) have been isolable,
which are soluble ﬁbril-like species formed during the postnucleation stage (Fig. 1). PFs are biophysically well-characterized
and show propensity to both elongate and laterally associate to
grow into mature ﬁbrils [16]. Only a handful of low-molecular
weight oligomers have been successfully isolated [17–19]. However, the inability to isolate bonaﬁde on-pathway intermediates
as well as the lack of extrinsic molecular probes to precisely
monitor the dynamics during pre-nucleation have impeded the
progress towards understanding the process of nucleation. Furthermore, stochasticity causes variations in nucleation rates even
among identical microscopic molecules. Therefore, molecular-level

simulations are essential as they cater to the different temporal
scales along the aggregation pathway that can create modeling
stiffness.
In this report, we provide insights into Aβ aggregation by modeling key elements of the process involved based on a simple homogenous aggregation of Aβ molecules with a single unique nucleation event using two independent approaches with converging
solutions: (i) a reduced order stability argument and (ii) a mass
action kinetics based numerical simulation, supported by experimental biophysical data. Using such an approach, we have previously modeled reactions involving PFs, and established that the
parameter sweep for rate constants could be dramatically reduced
based on the stability argument [20]. Though employed on a simpler model system, the stability argument relies on a key physical requirement that the correct choice of nucleus, and hence n∗ ,
renders the equilibria stable. The ODE-based numerical simulations
were employed using a divide-and-conquer strategy by segmenting
the sigmoidal ﬁbril-growth curve into three stages (Fig. 1; inset) as
previously reported [21]. The data indicate a narrow range of critical nucleation number for Aβ aggregation that is in close agreement to other reports. More importantly, this report sheds insights
into understanding the critical nucleation event during Aβ aggregation from a new approach and methodology.
2. Experimental methods
Aβ 42 peptide was synthesized at the peptide synthesis facility
core at Mayo Clinic, Rochester, MN. Thioﬂavin-T (ThT) and other
chemicals were purchased from VWR Inc.
Aβ monomer preparation and aggregation. Lyophilized Aβ peptide was stored at −20 °C until use. Aβ monomers, free of any
preformed aggregates were prepared as previously described [22].
Brieﬂy, the peptide stocks were dissolved in 50 mM NaOH that was
left to stand at room temperature for 15 min before fractionating using Superdex-75 size exclusion chromatography column. The
samples were collected as 0.5 mL fractions upon isocratic elution
in 20 mM Tris, pH 8.0 buffer with a ﬂow-rate of 0.5 mL/min. The
fractions corresponding to monomers were collected individually
and were used as such. The concentrations were determined using UV–Vis absorbance at 280 nm and with an extinction coeﬃcient of 1450 cm−1 M−1 (www.expasy.org) corresponding to a tyrosine residue. All the experiments were performed either with
freshly puriﬁed monomers or monomers not more than two day
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old stored at 4 °C. Aggregation of Aβ at different concentrations
were initiated using freshly puriﬁed Aβ 42 (20 mM Tris, 50 mM
NaCl, pH 8.0) was incubated quiescently at 37 °C, and the aggregation kinetics was monitored by ThT ﬂuorescence and MALDI-ToF
mass spectrometry at different time points as described below.
Thioﬂavin-T ﬂuorescence. Fluorescence experiments were performed on a Cary Eclipse spectrometer (Varian Inc). Samples were
excited at 452 nm and the emission at 482 nm was monitored
in kinetic mode for one minute with a band width of 10/10 nm.
The averaged data point was considered for the overall kinetic plot.
Aggregation parameters were obtained by monitoring the reaction
with ThT ﬂuorescence and ﬁtting the data points to the sigmoidal
curve in Eq. (1) using Origin 8.5 software.

a

F=
1+ e

−



t−t0.5
b



(1)

In this equation t is time, a and b are ﬁxed parameters, and t0.5
is the time to reach half-maximal ThT ﬂuorescence. Lag times are
equal to t0.5 − 2b for each ﬁtted curve.
Mass spectrometry. Monomer depletion during aggregation was
monitored using MALDI-ToF mass spectrometry (Bruker Inc). Insulin sample were used as internal standards to calculate the absolute concentrations of Aβ 42 in the sample as previously shown
[23]. Typically, 2 μL aliquot of sample from each incubations at
different time points (20–100 pmol of samples for 10–50 μM Aβ
incubations) and mixed with 16 pmol of insulin (1 μL sample) for
each sample in the matrix. The solution was mixed with a saturated solution of α -Cyano-4-hydroxycinnamic acid (CHCA) matrix
in acetonitrile and water before spotting on a MSP AnchorChip
600/96 plate (Bruker Daltonics Inc, Germany). Prior to the start of
each experiment, parameters in MALDI-ToF instrument were optimized and calibrated using molecular weight standards (Protein
Calibration Standard-1; Bruker Daltonics). The detection limit in
the spectrometer was set at 2X with a laser power of 51% in reﬂectron mode. For each spot/time points, 700 shots were collected
and averaged to obtain the ﬁnal plot. The plots were normalized
based on insulin intensity shown in Eq. 2 as previously reported
[23].

Normalized Intensity =

IntAβ
IntAβ + Intinsulin

(2)

3. Preliminary observations: stability analysis
As a ﬁrst step towards validating our hypothesis that the critical nucleation number, n∗ , falls within a narrow range of molecular mass in a homologous single nucleation model, the stability
analysis was performed on a simpliﬁed, reduced order mass action based model. The rate constants derived from this study was
used as a preliminary lead for a more detailed numerical model
presented in the second part of this section to determine n∗ . The
equilibria obtained from the numerical model were also employed
in the perturbation analysis resulting in an optimal feedback between perturbation and numerical arguments.
In order to see whether the molecular weight of nucleus is conserved or conﬁned within a narrow range of masses, a linear stability analysis was employed on a simple three-species model containing monomers (A1 ), nucleus (An∗ ) and ﬁbrils (F). Since the rate
constants for the system of equations are not known at the outset, the system remains unsolvable. We argue that after perturbing
the system, the rate constants involved in the dissapearance of the
perturbed species must reﬂect those involved in the formation of
the species. In terms of the energetics involved in aggregation, it
can be said that at any point in time, any stable perturbation that
drives the system off course will eventually die and bring the system back to its course. This is mathematically tractable only in the

equilibrium state and could yield valuable information about the
system. Our earlier analysis using such an algorithm has yielded
important information on PFs [20], and this has been used to reduce the parameter search space in our numerical simulations as
discussed later.
Mathematically, we represent the three-species system by:

[A1 + A1 + · · · · · · + A1 ]n∗ = An∗
[An∗ + An∗ + · · · · · · + An∗ ]s∗ = F
In accordance with this simplistic scheme, a critical number (n∗ )
monomers aggregate to form the nucleus and a certain number
of nuclei (denoted s∗ ), in turn aggregate to form the ﬁbrils. For
sake of simplicity, any combination of monomers and nuclei which
could result in the formation of the ﬁbrils is disregarded here. As
in our previous reports, PFs, which are smaller than ﬁbrils are assumed to be composed of 1600mers [24], and for simplicity, in this
analysis we have assumed ﬁbrils (F) to be of the same size too.
This allows us to estimate the critical number of nuclei required to
form the ﬁbril, namely s∗ = | 1600
n∗ | . The terms kij (i,j = m,n,p) refer
to the forward and backward reaction rates. It must be noted that
the nucleation number, n∗ is unknown at this stage and is the key
parameter to be determined. In order to ﬁnd n∗ , we test the differential equation resulting from the above scheme (Eq. (3)–(5) below) for all integers, n, in a large range dictated by the biophysics.
The set of n∗ values is then a special subset of n and chosen based
on which n yields physically meaningful results as discussed in detail below.
The corresponding nonlinear differential equations for our
model system, based upon mass action kinetics, are then given by

dA1
= n(−kmn An1 + knm An )
dt

(3)



dAn
= s −knp Asn + kpn F + kmn An1 − knm An
dt

(4)

dF
= knp Asn − k pn F
dt

(5)

Here An results from the aggregation of n monomers and F from
the aggregation of ‘s’ An ‘s’. The objective of this study was to ﬁnd
the optimal set of n∗ , by varying 1 ≤ n ≤ |F| (where |F| refers to the
magnitude of the ﬁbrils or the number of monomeric units that
compose ﬁbrils) that keeps the equilibrium concentration of the
various species stable for suﬃciently small perturbations applied
to the system. Let Me , Fe , Ne be the equilibrium concentrations of
the monomers, ﬁbrils and nucleus, respectively, corresponding to
the steady state version of the Eqs. (3)–(5). For the Eqs. (3)–(5)
to be physically meaningful, the equilibrium state for this system
must be mathematically stable, and any perturbation to the system, if suﬃciently small, must eventually disappear. Therefore, stable equilibria conditions were derived upon linear perturbation of
the stable solutions Me , Fe , Ne . Based on the above mentioned
mathematical treatment, the concentrations of the different species
can be written in the form

A1 = Me + ε M1 , An = Ne + ε N1 , F = Fe + ε F1

(6)

where M1 , F1 , N1 represent perturbed concentrations and ε is
the magnitude or order of the perturbation. The above expression
Eq. (6) for A1 , An , F were placed into Eq. (3)–(5) and the O(ε ) were
collected, giving the perturbed system



dM1
= n knm N1 − nkmn Men−1 M1
dt


dN1
= s k pn F1 − sknp Nes−1 N1 + nkmn Men−1 M1 − knm N1
dt

(7)
(8)
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dF1
= sknp Nes−1 N1 − kpn F1
dt
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(9)

To see whether the perturbations disappear, these equations were
written in the operator form

d[X]
= [Y ][X]
dt

(10)

Where the matrices [X], [Y] are respectively represented by

[X] = {M1 , F1 , N1 },

⎛
⎜

[Y ] = ⎝

−n2 kmn Men−1

nknm

0

nkmn Men−1 −knm − s2 knp Nes−1 skpn
0

sknp Nes−1

⎞
⎟
⎠

(11)

−kpn

Our objective was to seek the range of the rate constants in which
the real part of all the eigenvalues of the matrix [Y] remain simultaneously negative (i.e. the perturbations eventually vanish). Due
to the presence of several parameters, some restrictions were imposed for computation based on experimental data. This included
the assumption that at thermodynamic equilibrium after inﬁnite
time, 99.9% of the monomers are depleted and 98.9% of the initial
monomers are converted into ﬁbrils leaving 1% to remain as the
nuclei. In other words, Me = 0.001Fe and Ne = 0.001Fe . The value
of knp was assumed to be knp = 0.9 s−1 based on our previous report [20]. The parameters, n, kmn , Fe along with the ﬁbril size were
then varied. The reverse rates,
0.9Ns
k Mn
k pn = Fe e = 0.9(0.1s )Fes−1 and knm = mnFe e = kmn 10−3n+2 Fen−1
were obtained from equilibrium conditions. By sweeping over n
and ﬁxing all the other parameters, the eigenvalues of the perturbed system were analyzed for those values that were simultaneously negative, which would render the equilibrium state, stable. The n’s corresponding to the stable states are denoted n∗ .
Fig. 2 shows a plot of the logarithm of the absolute values of
the three eigenvalues of the system versus n∗ . The interesting aspect of the plot is that this select group of ‘stable’ n∗ values is
small and ﬁnite and conﬁned to a narrow range 10 < n∗ < 60
for the most part. For all other cases of n, at least one of the
eigen values becomes positive making the perturbation unstable.
The range of n∗ is sensitive to the choice of ﬁbril size and the order of magnitude of Fe , namely k (such that Fe = 10−k ), which
is one of the primary variables in our study. The magnitude of n∗
increases with increasing magnitude of the ﬁbrils and decreases
with increasing values of k (Fig. 2B). However, the key observation here is that no matter the size of the ﬁbrils, which can
range between 3000 and 5000mers, n∗ is restricted to a fairly
tight range (10–60). This mathematical analysis support our hypothesis that the n∗ could be narrow in range that could potentially play a signiﬁcant role in the fate of the overall aggregation
process.
Based on perturbation analysis described above, having observed that the nucleation event is not random but could be
tightly-controlled with a narrow range of molecular mass in a homologous mechanism, we sought to determine more rigorously,
how many monomers are associated within the nucleus (n∗ ) by
experimental and computational methods. First, the concentration
dependence of Aβ 42 aggregation was experimentally established.
Four different concentrations, 20, 30, 40 and 50 μM of freshly puriﬁed, buffered Aβ 42 monomers were subjected to aggregation in
quiescent conditions at 37 °C. The reactions were monitored using
the ThT ﬂuorescence assay. All the samples exhibited a sigmoidal
growth curve with a lag time, growth phase and saturation, indicative of a nucleation-dependent process (Fig. 3A). As expected, increase in monomer concentration resulted in increased rate of aggregation and consequently reduced the lag-times. The data were
ﬁt with Eq. (1) revealed the lag times of 28.3, 22.1, 18.3 and 16.9 h

Fig. 2. Prediction of n∗ by stability analysis. (A) Logarithm of the absolute values of
real parts of the three eigenvalues of the perturbed system Eq. (7)–(9). The graph
shows the eigenvalues only when all three values are simultaneously negative, suggesting linear stability. The n∗ values corresponding to the open circles are the allowable values for the nucleation size. (B) The variations in the n∗ as a function of
ﬁbril concentration index k, where the concentration is taken to be Pe = 10− k . Note
that for any given value of k, ﬁbril size, several n∗ ’s are mathematically permissible,
indicated by the error bars in the plot.

for 20, 30, 40 and 50 μM reactions, respectively. The semi-log plot
of Aβ concentration and the calculated lag-time showed an expected linear dependency (Fig. 3B). In addition, a linear relationship was also observed between Aβ concentration and saturating
values of ThT ﬂuorescence (Fig. 3C).
4. ODE-based simulations
Modeling approach. A ‘divide and conquer’ strategy was adopted
by simplifying the overall aggregation into three experimentally
and computationally-viable parts such as pre-nucleation (Stage
I), post-nucleation (Stage II) and protoﬁbril reactions (Stage III)
(Fig. 1), without compromising the reactions involved in aggregation. Needless to say, it is imperative to compute the kinetic rate
constants involved in all the different stages to simulate the overall aggregation process. Pre-nucleation events, which are subjected
to intense scrutiny lately and are the focus of this report, occur
at Stage I. The forward and backward rate constants in this Stage
are designated as knu,i and knu-, respectively. The rate-limiting step
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Fig. 3. Aβ aggregation reactions. (A) Aliquots of Aβ aggregation reactions with 20
(), 30 (●), 40 (), and 50 μM ( ) monomer concentrations in 20 mM Tris, 50 mM
NaCl at pH 8.0 were periodically removed and analyzed by ThT ﬂuorescence assay.
The data were ﬁt to sigmoidal equation (Eq. (1)). (B) and (C) The lag time and peak
intensity were plotted against Aβ concentration to obtain the expected linear ﬁts.

of nucleation is followed by a growth phase, which is dominated
by aggregation reactions (Stage II) [4,25]; the forward and backward rate constants in this stage are designated by kfb,i and kfb- respectively. Stage III involves the formation of PFs that are known
to follow elongation (forward and backward rate constants designated as kel, and kel- respectively) and association mechanisms
(forward and backward rate constants designated by kla and klarespectively) towards ﬁbrils [16,26–30] (Fig. 1). Using ODE-based
approach, we have previously modeled Stage III of aggregation involving PF elongation and lateral association, and obtained key rate
constants for the reactions [24]. It is noteworthy that for the reactions involved in Stage III ﬁxed rate constants were used primarily to reduce the number of parameters. However, this strategy did not affect our simulation because within this stage, as
the size of aggregates involved in these reactions are large, only
negligible differences in reaction rates occur due to their respective diffusivities. Our divide and conquer approach will help reduce the number of parameters that need to be computed simultaneously (forward and backward rate constant pairs for every
reaction, as well as the n∗ ). However, to facilitate the computation further, the following speciﬁc rational assumptions were made
based on established experimental and theoretical evidence. Energetically, during the pre-nucleation phase (Stage I), the concentration of monomers and low-molecular weight oligomers (dimers,
trimers etc.) are in a dynamic ﬂux with each other until the formation of the nucleus [7,9,31–33]. The pre-nucleation reactions
constitute the rate-limiting events during aggregation and hence,
generate the observed lag times during sigmoidal ﬁbril growth.
Based on the observed experimental bulk rates of reaction, we assume that for pre-nucleation reactions, the forward rate constants
of formation become progressively larger for larger aggregates towards the nucleus (knu,1 < knu,2 << knu,n∗ ). Furthermore, for
simplicity sake, a single backward rate constant, knu- was considered during this Stage based on the assumption that the backward rate constant is independent of the aggregate size. The basis for such an assumption comes from the previous report by

Fig. 4. (A) Reactions considered during the pre- and post-nucleation stages in the
modiﬁed model. (B) Reactions considered for Stages I, II and III in the detailed model.
In these equations, Ai represents the aggregate of ith order, for example, A1 is
monomer, A2 is dimer etc. and n∗ the nucleation number.

Serio and colleagues, who showed that increasing the number of
seeding ﬁbril ends by sonication could increase the reaction rates
signiﬁcantly [34]. This suggests that the detachment of monomers
mostly occur at the terminal rather than in the internal segment of
the aggregate. Hence, we assumed that the number of monomers
within an oligomer does not affect the backward rates signiﬁcantly.
Described below are the two closely-related modeling paradigms
called modiﬁed and detailed models that will be utilized in this
work.
The modiﬁed model. Our proposed model is based on the one
that was developed for insulin aggregation by Lee and co-workers
[15], and has been modiﬁed speciﬁcally for the Aβ . Aggregation
pathway has been characterized by a set of biochemical reactions (Fig. 4A) for which the corresponding reaction ﬂuxes were
computed and differential equations were formulated for each
oligomer concentration as a function of time (Eq. 12). Solving the
set of homogeneous ODEs allows us to study the temporal dynamics (in terms of concentration change) of each oligomer in the
system.

Jnu, j = knu, j A1 Ai − knu− Ai+1 ;
J f b,i = k f b, i A1 F − k f b− F ;
dA1
= −2Jnu,1 −
dt

∀i = 1, . . . , n∗ − 1

∀i = 1, . . . , n∗ − 1

∗

n −1

Jnu,i − J f b,1

(12)

i=2

dA1
= Jnu, j−1 − Jnu,i − J f b,i ; ∀i = 2, . . . , n∗ − 1
dt
dF
= knu, n∗ −1 A1 An∗ −1 − knu− F ;
dt
Here, Ai ’s denote i-mers, n∗ is the nucleation number, Jnu,i
and Jfb,i refer to the ﬂuxes for nucleus and ﬁbrils respectively,
and F is a ﬁbril. The following assumptions were made for aggregation involving homogenous, single nucleation mechanism:
(a) monomer adds to i-mers until ﬁbril formation, (b) nucleation
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involves monomer addition as well as a structural change in the
aggregate, An∗ (this conformational change is implicit), (c) postnucleation events are relatively faster, as the forward rate constants for post-nucleation are much higher than those in prenucleation (i.e., knu,n∗ +i >>knu,i ) ( ∼108 fold difference was reported
in [15] for insulin aggregation), (d) the reverse reaction rate constants are assumed to be independent of size i, and abbreviated
as knu- and kfb - and, (e) aggregation under agitation conditions are
known to drastically decrease the lag-times. Therefore, knu,i and
kfb,i are assumed to be diffusion-limited; using the Stokes–Einstein
equation, the diffusivity is proportional to the inverted cubic root
of i, resulting in:



knu, j =

1
1
1
knu,1 1 + √
; k f b,i √
3
3
2
i
i
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Rationale for simulation with modiﬁed and detailed models. In
order to achieve both simulation accuracy and ease, both the
modiﬁed model and the detailed model were used in tandem for
Aβ aggregation. Since the primary objective of this report is
estimating n∗ , the modiﬁed model is adequate, which computes
Stages I and II. Our rationale to incorporate the detailed model
are (a) to investigate the dependence of n∗ on PF size observed
from stability analysis described above, and (b) to validate our
simulation by accounting monomer depletion, which will require
simulation of the entire aggregation pathway. Therefore, modiﬁed
model was used to study the lag times of aggregation exclusively,
generated for different values of n∗ as presented in Fig. 5, while
the detailed model was used for validation.

(13)

Based on these assumptions, the reaction ﬂuxes and differential
equations are derived as shown in Eq. 12. Note that assumption
(e) mentioned above helps in drastically reducing the number of
parameters to be estimated in the pathway by relating all the forward rate constants in Stages I and II to the ﬁrst rate constant for
each respective stage (i.e., knu,1 and kfb,1 ). Importantly, it greatly reduces the complexity involved in incorporating PF as a parameter.
This model, however, does not include the dynamics of Stage III,
protoﬁbril-to-ﬁbril transitions.
The detailed model. A complete simulation of the Aβ aggregation requires an estimate of the following six parameters: knu,1 ,
kfb,1 , knu- , kfb- , n∗ and b (see Fig. 1), where b is the mapping constant that helps correlate the experimental ThT ﬂuorescence data
to concentration estimates as we have shown previously [24]. It
is a daunting task to make parameter sweep for individual reactions with different values for each of these variables to accurately
simulate the experimental plots due to the large solution space.
Hence, as mentioned earlier, the sigmoidal ﬁbril-growth curve was
dissected in three simpliﬁed stages as mentioned before to bring
down the number of parameters to be estimated together [24].
The pre- and post-nucleation stages are well-approximated by the
set of equations shown in Eq. 12. However, the stage involving PF
dynamics (Stage III) requires reactions from both post-nucleation
(Stage II) and PF elongation/lateral associations to be combined. Assuming that ﬁbrils can potentially reach up to about at least 3200mers (they can range much more than this but this conservative
lower limit is appropriate for our models), 3200 different species
have to be considered within the simulation and hence, a similar
number of differential equations have to be included to study their
change with concentration. Furthermore, many aggregates along
the pathway could potentially interact with one another, one needs
to consider 3200 C2 combinations of possible reactions between
them, which renders the problem mathematically intractable. A viable approach would be to consider monomer addition reactions
until the formation of 1600-mers in the system (which is approximated to be the average PF size (19)), and then to include our previously established PF elongation and lateral association reactions.
We call this as the detailed model for which the complete set of
reactions is shown in Fig. 4B. Such an endeavor then necessitates
the estimation of four more bulk rate constants: the forward and
backward rate constants for the PF elongation and lateral association stage denoted by kel,1, kel-, kla and kla- , respectively. In our
previous report [24], we estimated the rate constants (kel,1 , kel- , kla
and kla- ) separately and veriﬁed them with in vitro experiments
as follows: kel,1 = 9.0 × 103 (h−1 μM−1 ), kel- = 4.5 × 102 (h−1 ),
kla = 9.0 × 10−1 (h−1 μM−1 ), kla- = 6.0 × 10−3 (h−1 ). Note that the
estimation of kfb,1 (in Stage II) automatically allows the calculation
of kfb, 1600-n∗ using Eq. (13); also, the PF elongation is considered to
be merely a continuation of the post-nucleation phase with kel,1 =
kfb, 1600-n∗ and kel- = kfb . Hence, the detailed model as shown in
Fig. 4B can now be simulated to obtain the lag-times.

5. Results
5.1. Lag time correlations derived from modiﬁed model
Based on the stability analysis shown in Fig. 2, the parameter
sweep for rate constants were greatly reduced to the plausible
range, 10 < n∗ < 60 as mentioned above, which was computed
using the modiﬁed model. Table 1 shows the simulated lag times
for different n∗ and initial Aβ concentration. In order to ﬁnd the
pre-nucleation rate constants along with n∗ , the rate constants that
give the maximum lag times for each value of n∗ were estimated.
Note that, changing the rate constants further to achieve higher lag
times render the system of differential equations unstable. Hence,
they were considered unrealistic and hence, discarded. Interestingly, the modiﬁed model shows four distinctly different regimes of
lag times corresponding to four different pairs of rate constants in
pre-nucleation (highlighted in Table 2). In parallel, this also characterizes four different regimes of n∗ values associated with Aβ
aggregation that are summarized as follows: Regime 1: n∗ = 7–11;
Regime 2: n∗ = 12–14; Regime 3: n∗ = 15–17; Regime 4: n∗ = 18–21.
The rate constants for each of these regimes are shown in Table 2.
Note that the forward rate constant, (knu,1 ) was ﬁxed for
each n∗ , while the others and backward rate constant were varied to achieve the highest lag times as reported in Table 1. It
is noteworthy that all the other n∗ values, i.e. n∗ < 7 and n∗
> 21 resulted in either (i) negative/ discontinuous simulations
or (ii) oscillatory nature of the ﬁbril growth curve (instead of
the expected sigmoidal behavior). Both of these are indicative
of poor convergence or in other words, physiochemically invalid
possibilities (data not shown). Fig. 5A shows the simulations (solid
lines) of Aβ aggregation for n∗ = 12 for 20, 30, 40 and 50 μM
monomer concentrations that showed canonical sigmoidal growth
curves. Overlay of the normalized experimental data obtained from
Fig. 3A shows a very good correspondence between the simulation
and experimental data (Fig. 5A). The bulk lag times for each
initial monomer concentration and for each n∗ value were then
calculated using t0.5 − 2b term upon ﬁtting the curves with Eq. (1)
(Table 1). One of the important properties of Aβ aggregation is
Table 1
Lag times from simulation for various estimates of n∗ .
n∗

20 μM (h)

30 μM (h)

40 μM (h)

50 μM (h)

7
8
9
10
11
12
13
14

32.60
33.85
36.85
38.35
42.26
22.93
29.27
49.62

24.24
26.05
28.14
30.12
30.87
20.45
19.65
18.88

19.76
21.59
23.84
26.19
27.54
16.70
17.68
21.89

16.88
18.67
20.86
23.04
24.44
15.29
17.59
16.06

Expt

28.32

23.13

20.70

18.00
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Fig. 5. Overall simulation of aggregation. (A) Normalized ThT ﬂuorescence data shown in Fig. 3 with 20 ( ), 30 (), 40 ( ) and 50 ( ) μM Aβ . Corresponding lines are
obtained from the modiﬁed model (with a scaling factor, b of 6) for respective concentrations for n∗ = 12; 20 (red), 30 (black), 40 (navy) and 50 (green) μM Aβ . (B) Lag time
data obtained from the modiﬁed simulations for n∗ = 7–14 (Regimes 1 and 2) for these Aβ concentrations are compared to that obtained from the experiment (●). (C) Slope
derived from panel (B) (°) are plotted against the corresponding n∗ values (●). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)

the linear correlation between Aβ concentrations and lag times
(Fig. 3B). By plotting the lag times values obtained for various
n∗ simulations, largely linear correlations were obtained for
n∗ = 7–13, and among them n∗ = 12 and 13 showed the best
correlation with the experimental data (Fig. 5B and C). None of
the simulations above n∗ = 13 yielded meaningful data suggesting
those values could be improbable (data not shown).
5.2. Comparison of the simulated and experimental lag times
The experimental ThT ﬂuorescence plots provide an ensembleaveraged, cumulative effect of all aggregated forms. Hence, from
the simulation, one has to plot the cumulative effects from all
the nucleated oligomers that can be mapped directly to the experimental results. For the modiﬁed model, we assume that all nucleated species are ThT positive; hence the concentration of ﬁbrils, [F], at each time point was simply multiplied by a mapping
constant b to see if they were in agreement with the experimental data. The model however, needs to account for the oligomer
sizes as each of the oligomers at the post-nucleation stage such as,
An∗ , An∗ +1 ,…,A3200 would contribute to the bulk ThT ﬂuorescence

differently. In order to do this, the individual oligomer contributions to ThT at each value of the simulation time were computed
to a weighted average as shown below:
3200−n∗

b ∗ i ∗ [An∗ +1 ].

(14)

i=0

where [An∗ +i ] denotes the concentration of each nucleated species,
i denotes the number of Aβ molecules by which the oligomer
has elongated beyond n∗ and hence, the contribution of the corresponding oligomer towards the ﬂuorescence, and b is a constant
scaling factor to map to the ﬂuorescence sensitivity estimates. The
simulation curves shown in Fig. 5 plot the concentration of F based
on the assumption that all nucleated oligomers display ThT ﬂuorescence. The lag times estimated from the modiﬁed model were
still higher than that observed experimentally for Regimes 1, 3 and
4 as the rate constants were selected based on those that could
achieve maximum lag time for each n∗ . Hence, it can be argued
that Regime 2 (showing lower lag times than the experimental
data) might allow for more rate constant combinations to serve
as valid solutions and simulate the experimental growth curves
better. Also, it is diﬃcult to know what the minimum size of
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Table 2
Forward and backward rate constant values used in simulation. knu,1
is the forward rate constant value for the ﬁrst reaction during the
Stage I, and rest of the forward rate constants are computed based on
Stokes–Einstein equation (Eq. (13)). For each simulation these combinations of knu,1 , and the backward rate constant, knu- were ﬁxed.
Nucleation
number (n∗ )

Knu,1 (h−1 m M−1 )

Knu- (h−1 )

7
8

1.38 × 100
1.38 × 100

9.5 × 10−1
5.6 × 10−1

Regime 1

9
10
11

1.38 × 100
1.38 × 100
1.38 × 100

3.7 × 10−1
2.3 × 10−1
1.9 × 10−1

Regime 2

12
13
14

4.6 × 100
4.6 × 100
4.6 × 100

2.9 × 10−1
2.8 × 10−1
9.0 × 10−2

Regime 3

15
16
17

1.38 × 101
1.38 × 101
2.1 × 101

1.4 × 10−2
1.0 × 10−2
1.1 × 10−2

Regime 4

18
19
20
21

2.1 × 101
2.4 × 101
2.6 × 101
2.8 × 101

1.1
1.1
1.5
1.2

× 10−2
× 10−2
× 10−2
× 10−2

oligomers that show ThT ﬂuorescence from the experimental data
and hence, the experimental estimates are at best the maximum
limits of the lag times for each initial Aβ concentration reported
here. The data obtained from the modiﬁed model however, provides a plausible range of n∗ and generate important rate constants
that could be utilized in the detailed model.
5.3. Monomer depletion as model validation using the detailed model
The detailed model was used to simulate the monomer depletion, which requires the knowledge of dynamics along the
entire pathway. While simple monomer additions were assumed
for Stages I and II, the following conditions were considered for
the reactions within the Stage III: The last forward rate constant
at Stage II was used as the starting point for each of the PF
elongation reactions (kfb ,1600-n∗ = kel,1 ). As mentioned before, due
to their large size, rate constants involving individual PF reactions
were assumed not to vary much owing to small differences in
their respective diffusivities. In addition, the lateral association
reactions used in the abstraction scheme (Fig. 4A) consider A3200
as the ﬁbril size (for simplicity). We treat all the reactions alike
or in other words, lateral association of A1600 + i, (i = 0,…,1599)
and A1600 will still produce an A3200 . A similar strategy was used
in our previous report (19). Rate constant values derived from the
mathematical stability argument were also utilized to narrow the
parameter space. The rate constants thus obtained were directly
incorporated within the detailed model to generate the monomer
depletion curves for validation.
Although ThT ﬂuorescence has served as a benchmark for analyzing amyloid aggregation, binding of ThT to amyloid ﬁbrils is
poorly characterized. Precise stoichiometry of ThT-to-Aβ is unclear
and hence, quantitative assessments could not be made accurately.
Since the aggregation data shown in Fig. 3 will be used for our
computational analyses described below, we wanted to ensure a
precise quantitative evaluation of the aggregation process. Generation and quantitative analysis of any homogeneous aggregate
along the aggregation pathway is nearly impossible to achieve, as
the dynamic nature of aggregation precludes experimental isolation of speciﬁc aggregates for quantitative measurements. However, quantitative assessment can be made on monomers by monitoring their disappearance during aggregation. To do so, we employed matrix-assisted laser desorption ionization-time of ﬂight

Fig. 6. Monomer depletion data along with simulation overlap. (A) Analysis of Aβ
aggregation (50 μM) shown in Fig. 3A by MALDI-ToF mass spectrometry containing
an internal standard, insulin at the indicated times of incubation. (B–E) Normalized
ThT intensities (°) along with quantitative monomer depletion data obtained from
MALDI-ToF (). Black line is the sigmoidal ﬁt from the detailed simulation to the
data points shown in Fig. 3A. The red line is monomer depletion data obtained
from detailed simulation. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)

(MALDI-ToF) mass spectrometric technique. MALDI-ToF is uniquely
suited for this experiment as this soft ionization technique ensures
no dissociation of preformed aggregates and hence enables quantiﬁcation of unreacted monomers exclusively. As described in Experimental Methods, aliquots of the samples from Aβ reactions
shown in Fig. 3 were plated on a MALDI plate along with a constant amount of insulin as an internal standard. A similar method
for quantifying monomeric Aβ using insulin as internal standard
was adopted by Zovo and co-workers [23]. As shown in Fig. 6A, a
50 μM Aβ reaction analyzed by MALDI-ToF at various time points
of incubation showed two major peaks corresponding to the unreacted Aβ 42 monomer (4513 a.m.u) along with the insulin standard
(5808 a.m.u). Over time, the intensity of Aβ 42 monomers diminished correlating with aggregation. A plot of monomer intensities
normalized based on intensities of insulin standards (see Experimental Methods) against incubation times resulted in monomer
depletion curve (; Fig. 6B). It is interesting to note that the
monomer depletion curve did not display a sigmoidal pattern of
decay with a lag phase observed for the corresponding aggregation
reaction (◦; Fig. 6B). Instead, an exponential pattern was observed
without any observable lag times. This pattern was consistent for
the rest of the aggregation reactions (20–40 μM Aβ 42; Figs. 4C–
E). Using the same parameters for the detailed model, plots for
monomer disappearance were obtained for n∗ =12. The red lines
in Figs. 6B–E indicate these simulate curves obtained from the detailed model, which correlate well with the experimental monomer
depletion data obtained. Higher rates of monomer depletion observed for the simulated curves is expected as the simulation using
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detailed model is able to account for every individual reaction than
the experimentally observed ones, which the ThT is incapable of
capturing. This is the likely reason for the absence of a complete
overlap between the experimental and the simulation data. Nevertheless, the exponential decay of monomer depletion observed
from the mass spectrometric analysis is captured within the simulation by the detailed model.
6. Discussion
In this report, we have investigated the range of monomers
that can associate to form a nucleus during Aβ aggregation–
in other words, the nucleation number, n∗ , for a homogenous,
single nucleation model. As mentioned earlier, many groups have
attempted to identify the critical mass of the nucleus for amyloid
proteins by a variety of different approaches. More importantly,
the pre-nucleation dynamics has been under intense debate and
the presence of secondary nucleation, heterogeneity in both conformation and molecular mass and even conformationally-changed
monomer as a nucleus have been proposed [11,35–37]. Here, we
have adopted a simplistic model of homogenous Aβ aggregation
involving single unique nucleation event, and delineated the process by modeling key elements by two independent approaches
with converging solutions: a reduced order stability argument
and ODE-based numerical simulations, supported by experimental
data. First, the reduced-order model stability analysis yielded a
range between 10 and 60 mers to be the possible range of n∗ .
The subsequent numerical simulation provided a range between
7 and 21 mers for n∗ . The larger range of n∗ from the stability
argument could be attributed to its simplistic form in comparison
to the numerical simulations. However, the overlap of 7–21 range
is noteworthy. Furthermore, keeping in mind the sizes of PFs
and ﬁbrils, which are in the order of 1600 and 5000mers, the
estimates of n∗ from the two evaluations seem to be in good
agreement. Furthermore, the reduced-order stability analysis
enables us to reduce the parameter sweep for the subsequent
analysis as we reported earlier [20]. Secondly, within the narrow
n∗ range determined by numerical analyses, the value of 12 shows
good correlation with the experimental values. Shoghi-Jadid and
co-workers approximately determined the n∗ value for Aβ to be
6 [38]. It is also noteworthy that Saric and co-workers elegantly
demonstrated the signiﬁcance of non-speciﬁc interactions during
the pre-nucleation phase [11]. More importantly, via atomistic
and coarse-grained models, the authors established a plausible
size nucleus to range between 6 and 14 depending on the initial
monomer concentration. The results derived from these reports are
in good agreement with our conclusions despite the differences
in the approaches. It has to be borne in mind that simulation
curves that we generated are not ‘model ﬁts’ to the experimental
data but simply an overlay of the two independent data. In other
words, the experimental data were not subject to curve ﬁtting
methods, and n∗ was obtained and veriﬁed by two independent
approaches.
It is also interesting to observe the variations in n∗ as a function
of PF concentration as modeled by our reduced order approach
(Fig. 2B). Similar results were obtained from numerical analysis
also (data not shown). Since only nucleus could have manifestations on the fate of PFs and not the other way around, the change
in PF concentrations as a function of n∗ suggest that the physiochemical or molecular nature of the nucleus could be responsible
for dictating the fate on the downstream events such as PF formation. This also brings up the possibility of the nucleus being
heterogeneous, as has been proposed for poly-Q aggregates [39].
Heterogeneity could arise from conformation, overall structure of
the oligomeric assembly or critical nucleation number, n∗ . It may
not be necessary to have n∗ to be conserved for Aβ aggregation

and could vary depending on the aggregation condition and environmental factors. A more likely scenario could be that n∗ may
never be a single value but rather, a range between speciﬁc values
similar to the one we have presented in this report (n∗ = 7 and
14). Within the numerical heterogeneity, the nucleus could also be
conformationally heterogeneous. Nevertheless, our simpliﬁed homogenous, single nucleation model has provided key insights in
the dynamics of the system. It is clear that the nucleation number
could only be within a tight range of values as determined in this
report. The effects of physiochemical and structural nature of nucleus on aggregation are currently being investigated and will be
reported at a later date. Nevertheless, the current report presents
the dynamics of Aβ aggregation from a different approach and
opens the door in investigating the other possibilities of multiple
nuclei and heterogeneous nucleation during Aβ aggregation in the
future.
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